Modalis Therapeutics Corporation focuses on discovering and developing treatments for severe genetic conditions. The company utilizes its proprietary CRISPR-GNDM technology to…
Ranked competitors and alternatives for this company are available inside Xcout Intel. Subscribe to open it.
Subscribe to see モダリス →Already a subscriber? Sign in
Xcout Intel tracks モダリス continuously — this profile deepens as new filings, funding, people and hiring data arrive.